Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Markets
Screener
News
About

CARL - Carlsmed, Inc. Latest News | Finranks

Home

CARL

C

Carlsmed, Inc. (CARL)

NMS – Real Time Price. Currency in USD

9.66

-0.20 (-2.03%)

At close: Mar 27, 2026, 4:00 PM EDT

9.66

0.00 (0.00%)

After-hours: Mar 27, 2026, 4:10 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Carlsmed, Inc. (CARL) Q4 2025 Earnings Call Transcript

Carlsmed, Inc. (CARL) Q4 2025 Earnings Call Transcript

Carlsmed, Inc. (CARL) Q4 2025 Earnings Call Transcript

Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results

Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results

Fourth quarter revenue of $15.2 million; 61% growth YoY Full year revenue of $50.5 million; 86% growth YoY CARLSBAD, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025.

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans, LA.

Carlsmed Announces first corra™ personalized Cervical Plating Procedure

Carlsmed Announces first corra™ personalized Cervical Plating Procedure

The corra™ Cervical Plating System marks the debut of Carlsmed's patient-specific fixation portfolio The corra™ Cervical Plating System marks the debut of Carlsmed's patient-specific fixation portfolio

Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

CARLSBAD, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its fourth quarter and full year 2025 financial results after market close on Wednesday, February 25, 2026. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time.

Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure

Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure

CARLSBAD, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the successful completion of the first posterior lumbar spine surgery using the Company's aprevo® Lumbar Bi-lateral Posterior System.

Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025

Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025

Fourth quarter 2025 revenue of ~$15.2 million, representing ~61% growth over Q4 2024 Full Year 2025 revenue of ~$50.5 million; representing ~86% growth over 2024

Videos

No Data

There is no data to display

Press releases

Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results

Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results

Fourth quarter revenue of $15.2 million; 61% growth YoY Full year revenue of $50.5 million; 86% growth YoY CARLSBAD, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025.

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans, LA.

Carlsmed Announces first corra™ personalized Cervical Plating Procedure

Carlsmed Announces first corra™ personalized Cervical Plating Procedure

The corra™ Cervical Plating System marks the debut of Carlsmed's patient-specific fixation portfolio The corra™ Cervical Plating System marks the debut of Carlsmed's patient-specific fixation portfolio

Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure

Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure

CARLSBAD, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the successful completion of the first posterior lumbar spine surgery using the Company's aprevo® Lumbar Bi-lateral Posterior System.